PortfoliosLab logoPortfoliosLab logo
BIO vs. TMO
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

BIO vs. TMO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Bio-Rad Laboratories, Inc. (BIO) and Thermo Fisher Scientific Inc. (TMO). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

BIO vs. TMO - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
BIO
Bio-Rad Laboratories, Inc.
-8.13%-7.77%1.74%-23.21%-44.35%29.61%57.54%59.34%-2.70%30.94%
TMO
Thermo Fisher Scientific Inc.
-14.57%11.78%-1.72%-3.36%-17.29%43.54%43.72%45.55%18.21%35.03%

Fundamentals

Market Cap

BIO:

$7.52B

TMO:

$186.44B

EPS

BIO:

$28.09

TMO:

$17.77

PE Ratio

BIO:

9.91

TMO:

27.83

PS Ratio

BIO:

2.92

TMO:

4.19

PB Ratio

BIO:

1.01

TMO:

3.49

Total Revenue (TTM)

BIO:

$2.58B

TMO:

$44.56B

Gross Profit (TTM)

BIO:

$1.34B

TMO:

$18.02B

EBITDA (TTM)

BIO:

$288.60M

TMO:

$11.35B

Returns By Period

In the year-to-date period, BIO achieves a -8.13% return, which is significantly higher than TMO's -14.57% return. Over the past 10 years, BIO has underperformed TMO with an annualized return of 7.16%, while TMO has yielded a comparatively higher 13.56% annualized return.


BIO

1D
-0.14%
1M
-0.44%
YTD
-8.13%
6M
-6.57%
1Y
15.98%
3Y*
-16.55%
5Y*
-13.65%
10Y*
7.16%

TMO

1D
0.61%
1M
-2.66%
YTD
-14.57%
6M
-6.66%
1Y
2.77%
3Y*
-4.68%
5Y*
1.90%
10Y*
13.56%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

BIO vs. TMO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BIO
BIO Risk / Return Rank: 5353
Overall Rank
BIO Sharpe Ratio Rank: 5454
Sharpe Ratio Rank
BIO Sortino Ratio Rank: 5151
Sortino Ratio Rank
BIO Omega Ratio Rank: 5050
Omega Ratio Rank
BIO Calmar Ratio Rank: 5454
Calmar Ratio Rank
BIO Martin Ratio Rank: 5555
Martin Ratio Rank

TMO
TMO Risk / Return Rank: 3939
Overall Rank
TMO Sharpe Ratio Rank: 4343
Sharpe Ratio Rank
TMO Sortino Ratio Rank: 3838
Sortino Ratio Rank
TMO Omega Ratio Rank: 3737
Omega Ratio Rank
TMO Calmar Ratio Rank: 4040
Calmar Ratio Rank
TMO Martin Ratio Rank: 4040
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BIO vs. TMO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Bio-Rad Laboratories, Inc. (BIO) and Thermo Fisher Scientific Inc. (TMO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


BIOTMODifference

Sharpe ratio

Return per unit of total volatility

0.37

0.09

+0.29

Sortino ratio

Return per unit of downside risk

0.89

0.38

+0.51

Omega ratio

Gain probability vs. loss probability

1.11

1.04

+0.07

Calmar ratio

Return relative to maximum drawdown

0.58

-0.01

+0.59

Martin ratio

Return relative to average drawdown

1.41

-0.02

+1.43

BIO vs. TMO - Sharpe Ratio Comparison

The current BIO Sharpe Ratio is 0.37, which is higher than the TMO Sharpe Ratio of 0.09. The chart below compares the historical Sharpe Ratios of BIO and TMO, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


BIOTMODifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.37

0.09

+0.29

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.38

0.07

-0.45

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.21

0.52

-0.31

Sharpe Ratio (All Time)

Calculated using the full available price history

0.26

0.41

-0.14

Correlation

The correlation between BIO and TMO is 0.37, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

BIO vs. TMO - Dividend Comparison

BIO has not paid dividends to shareholders, while TMO's dividend yield for the trailing twelve months is around 0.36%.


TTM20252024202320222021202020192018201720162015
BIO
Bio-Rad Laboratories, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
TMO
Thermo Fisher Scientific Inc.
0.36%0.30%0.30%0.26%0.22%0.16%0.19%0.23%0.30%0.32%0.43%0.42%

Drawdowns

BIO vs. TMO - Drawdown Comparison

The maximum BIO drawdown since its inception was -83.64%, which is greater than TMO's maximum drawdown of -71.16%. Use the drawdown chart below to compare losses from any high point for BIO and TMO.


Loading graphics...

Drawdown Indicators


BIOTMODifference

Max Drawdown

Largest peak-to-trough decline

-83.64%

-71.16%

-12.48%

Max Drawdown (1Y)

Largest decline over 1 year

-24.49%

-27.31%

+2.82%

Max Drawdown (5Y)

Largest decline over 5 years

-73.77%

-40.95%

-32.82%

Max Drawdown (10Y)

Largest decline over 10 years

-73.77%

-40.95%

-32.82%

Current Drawdown

Current decline from peak

-66.29%

-24.98%

-41.31%

Average Drawdown

Average peak-to-trough decline

-27.59%

-17.97%

-9.62%

Ulcer Index

Depth and duration of drawdowns from previous peaks

10.10%

12.13%

-2.03%

Volatility

BIO vs. TMO - Volatility Comparison

Bio-Rad Laboratories, Inc. (BIO) and Thermo Fisher Scientific Inc. (TMO) have volatilities of 9.14% and 8.84%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


BIOTMODifference

Volatility (1M)

Calculated over the trailing 1-month period

9.14%

8.84%

+0.30%

Volatility (6M)

Calculated over the trailing 6-month period

25.57%

19.06%

+6.51%

Volatility (1Y)

Calculated over the trailing 1-year period

42.95%

32.87%

+10.08%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

36.30%

26.59%

+9.71%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

33.45%

25.93%

+7.52%

Financials

BIO vs. TMO - Financials Comparison

This section allows you to compare key financial metrics between Bio-Rad Laboratories, Inc. and Thermo Fisher Scientific Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.002.00B4.00B6.00B8.00B10.00B12.00BAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
693.20M
12.22B
(BIO) Total Revenue
(TMO) Total Revenue
Values in USD except per share items